Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Type of study
Language
Publication year range
1.
Epilepsy Behav ; 150: 109568, 2024 Jan.
Article in English | MEDLINE | ID: mdl-38141572

ABSTRACT

OBJECTIVE: We aimed to investigate sleep disorders in patients with epilepsy (PWE) and to investigate the effects of sleep disorders on quality of life. METHODS: In our multicenter study conducted in Turkey, 1358 PWE were evaluated. The demographic and clinical data of the patients were recorded. The Insomnia Severity Index (ISI), Epworth Sleepiness Scale (ESS), Pittsburgh Sleep Quality Index (PSQI), Beck Depression Inventory (BDI), and Quality of Life in Epilepsy Inventory-10 (QOLIE-10) were administered. RESULTS: The mean age of 1358 patients was 35.92 ±â€¯14.11 (range, 18-89) years. Seven hundred fifty-one (55.30 %) were women. Some 12.7 % of the patients had insomnia (ISI > 14), 9.6 % had excessive daytime sleepiness (ESS > 10), 46.5 % had poor sleep quality (PSQI > 5), and 354 patients (26.1 %) had depressive symptoms (BDI > 16). The mean QOLIE-10 score was 22.82 ±â€¯8.14 (10-48). Resistant epilepsy was evaluated as the parameter with the highest risk affecting quality of life Adjusted odds ratio (AOR = 3.714; 95 % confidence interval (CI): [2.440-5.652] < 0.001)). ISI (AOR = 1.184; 95 % CI: [1.128-1.243]; p < 0.001), ESS (AOR = 1.081; 95 % CI: [1.034-1.130]; p < 0.001), PSQI (AOR = 0.928; 95 % CI: [0.867 - 0.994]; p = 0.034), BDI (AOR = 1.106; 95 % CI: [1.084-1.129]; p < 0.001), epilepsy duration (AOR = 1.023; 95 % CI: [1.004-1.041]; p = 0.014), were determined as factors affecting quality of life. SIGNIFICANCE: Sleep disorders are common in PWE and impair their quality of life. Quality of life can be improved by controlling the factors that may cause sleep disorders such as good seizure control, avoiding polypharmacy, and correcting the underlying mood disorders in patients with epilepsy.


Subject(s)
Epilepsy , Sleep Initiation and Maintenance Disorders , Sleep Wake Disorders , Female , Humans , Male , Epilepsy/complications , Quality of Life , Sleep , Sleep Initiation and Maintenance Disorders/complications , Sleep Wake Disorders/etiology , Surveys and Questionnaires , Turkey/epidemiology , Adolescent , Young Adult , Adult , Middle Aged , Aged , Aged, 80 and over
2.
Curr Med Imaging ; 2023 May 15.
Article in English | MEDLINE | ID: mdl-37189282

ABSTRACT

BACKGROUND: It is well-known that COVID-19 causes pneumonia and acute respiratory distress syndrome, as well as pathological neuroradiological imaging findings and various neurological symptoms associated with them. These include a range of neurological diseases, such as acute cerebrovascular diseases, encephalopathy, meningitis, encephalitis, epilepsy, cerebral vein thrombosis, and polyneuropathies. Herein, we report a case of reversible intracranial cytotoxic edema due to COVID-19, who fully recovered clinically and radiologically. CASE REPORT: A 24-year-old male patient presented with a speech disorder and numbness in his hands and tongue, which developed after flu-like symptoms. An appearance compatible with COVID-19 pneumonia was detected in thorax computed tomography. Delta variant (L452R) was positive in the COVID reverse-transcriptase polymerase chain reaction test (RT-PCR). Cranial radiological imaging revealed intracranial cytotoxic edema, which was thought to be related to COVID-19. Apparent diffusion coefficient (ADC) measurement values in the magnetic resonance imaging (MRI) taken on admission were 228 mm2/sec in the splenium and 151 mm2/sec in the genu. During the follow-up visits of the patient, epileptic seizures developed due to intracranial cytotoxic edema. ADC measurement values in the MRI taken on the 5th day of the patient's symptoms were 232 mm2/sec in the splenium and 153 mm2/sec in the genu. ADC measurement values in the MRI taken on the 15th day were 832 mm2/sec in the splenium and 887 mm2/sec in the genu. He was discharged from the hospital on the 15th day of his complaint with a clinical and radiological complete recovery. CONCLUSION: Abnormal neuroimaging findings caused by COVID-19 are quite common. Although not specific to COVID-19, cerebral cytotoxic edema is one of these neuroimaging findings. ADC measurement values are significant for planning follow-up and treatment options. Changes in ADC values in repeated measurements can guide clinicians about the development of suspected cytotoxic lesions. Therefore, clinicians should approach cases of COVID-19 with CNS involvement without extensive systemic involvement with caution.

3.
Cureus ; 13(11): e19848, 2021 Nov.
Article in English | MEDLINE | ID: mdl-34976483

ABSTRACT

COVID-19 disease causes various neurological disorders. Of these, stroke is the most devastating and difficult to manage in epidemic conditions. An increase in the rate of acute ischemic stroke in hospitalized coronavirus patients and stroke with large vessel occlusion due to COVID-19 disease have been reported in recent publications. The management of these patients is difficult and becomes even more challenging in epidemic conditions. A 71-year-old man suddenly developed left-sided weakness while he was hospitalized for COVID-19 disease. Cerebral computed tomographic angiography showed a terminus of the right internal carotid artery. The occluded vessel was completely recanalized by endovascular therapy. Left-sided hemiparesis resolved completely. As a result of this study, cryptogenic stroke was considered in the etiology of stroke. In this report, we present a case of stroke with COVID-19, who developed large vessel occlusion accompanied by splenic infarction while hospitalized due to COVID-19 disease and was successfully treated with endovascular thrombectomy under epidemic conditions.

SELECTION OF CITATIONS
SEARCH DETAIL
...